Last updated: 1 July 2020 at 1:58pm EST

Jeffrey Needham Net Worth




The estimated Net Worth of Jeffrey Needham is at least $2.7 Milione dollars as of 29 June 2020. Jeffrey Needham owns over 2,322 units of Perrigo plc stock worth over $859,343 and over the last 11 years Jeffrey sold PRGO stock worth over $1,837,567.

Jeffrey Needham PRGO stock SEC Form 4 insiders trading

Jeffrey has made over 13 trades of the Perrigo plc stock since 2014, according to the Form 4 filled with the SEC. Most recently Jeffrey exercised 2,322 units of PRGO stock worth $126,688 on 29 June 2020.

The largest trade Jeffrey's ever made was selling 10,205 units of Perrigo plc stock on 26 August 2014 worth over $1,515,851. On average, Jeffrey trades about 1,622 units every 86 days since 2013. As of 29 June 2020 Jeffrey still owns at least 32,149 units of Perrigo plc stock.

You can see the complete history of Jeffrey Needham stock trades at the bottom of the page.



What's Jeffrey Needham's mailing address?

Jeffrey's mailing address filed with the SEC is C/O PERRIGO COMPANY, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.

Insiders trading at Perrigo plc

Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen e Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.



What does Perrigo plc do?

perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).



Complete history of Jeffrey Needham stock trades at Perrigo plc

Persona
Trans.
Transazione
Prezzo totale
Jeffrey Needham
EVP e President CHC Americas
Opzione $126,688
29 Jun 2020
Jeffrey Needham
EVP e President CHC Americas
Opzione $157,383
6 Mar 2020
Jeffrey Needham
EVP e President CHC Americas
Opzione $318,691
31 Dec 2019
Jeffrey Needham
EVP e President CHC Americas
Opzione $428,089
8 Oct 2019
Jeffrey Needham
EVP e President CHC Americas
Opzione $64,998
26 Feb 2019
Jeffrey Needham
EVP e President CHC Americas
Vendita $321,717
12 Sep 2017
Jeffrey Needham
EVP e President CHC Americas
Opzione $86,347
21 Aug 2017
Jeffrey Needham
EVP e President CHC Americas
Opzione $37,518
31 May 2017
Jeffrey Needham
EVP e President CHC Americas
Opzione $122,271
22 Aug 2016
Jeffrey Needham
EVP e President CHC Americas
Opzione $31,039
19 Aug 2016
Jeffrey Needham
EVP e President CHC Americas
Opzione $180,723
21 Aug 2015
Jeffrey Needham
EVP e President CHC Americas
Vendita $1,515,851
26 Aug 2014
Jeffrey Needham
EVP e President CHC Americas
Opzione $216,369
22 Aug 2014


Perrigo plc executives and stock owners

Perrigo plc executives and other stock owners filed with the SEC include: